Table 1 National surveillance protocols for colorectal and endometrial cancer
Center | Series cencored | Colonoscopy | Gynecological examination | Reference no. and additional details | |||
|---|---|---|---|---|---|---|---|
Interval | From-to | Interval | From-to | Modalities in addition to clinical examination | |||
Finland | 2014 | 3 years | 1985–2014 | 1 year | 1995-2014 | EB, ultrasound, CA12-5 | |
Denmark | 2014 | 2 years | 1991–2014 | 2 years | 1991-2014 | US | [9] |
Germany | 2014 | 1 year | 1995–2014 | 1 year | 1995-2014 | US | |
Italy | 2013 | 1-2 years (1 year when age > 40 years; adenoma) | 1990–2013 | 2 years (1 years when age > 35 yrs.) | 1990-2013 | US, Pap smear | [11] |
UK (Manchester) | 2014 | 2 years | 1994–2014 | 1 year | 1990-2014 | Hysteroscopy, US, CA12-5 | [6] |
Sweden | 2014 | 2 years | 1990–2000 | 1 year | 1992-2014 | US, CA 12-5.Some patients: EB | |
18 months | 2000–2014 | ||||||
Australia | 2014 | 1 year | 1990–2014 | 1 year | 1990-2005 | US, EB, CA12-5 | https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp106_0.pdf https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp106_0.pdf |
2005-2014 | Risk reducing surgery only | ||||||
Spain | 2013 | 1-2 years (1 year when age > 40 years) | 1999–2013 | 1 year | 1999-2013 | US | Unpublished |
The Netherlands | 2013 | 2-3 years | 1987–1996 | 1-2 years | 1994-2005 | US | [7] |
2 years | 1997–2013 | 1-2 years | 2005-2013 | US, EB | |||
UK (Cardiff) | 2013 | 3 years | 1991–1994 | 1 year | 1998-2010 | US, CA12-5(3 or 4 monthly) | Unpublished Colonoscopy 96% compliance with interval. |
2 years | 1994–2013 | Gyn: only 27% of eligible women had gyn. Cancer screening. Since 2010 not systematic. | |||||
UK (Newcastle) | 2014 | 2 years | 1995–2014 | No fixed | Unpublished | ||
Norway | 2013 | 3 years | 1989–1996 | 2 years | 1989-2013 | US, CA12-5 | [5] |
2 years (one year when adenoma) | 1996–2013 | ||||||